Crystal Adam

President, R&DTango Therapeutics, Inc. (TNGX) · full profile →Form 4 · filed Aug 5, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$736K
Net Open-Market Flow
-$736K
Transactions
4
3 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Aug 3, 2026Option exercise(M)27K$5.20$140K143K
Aug 3, 2026Sell(S)5K$26.79$141K137K
Aug 3, 2026Sell(S)22K$27.35$594K116K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Aug 3, 2026Option exercise(M)27K$0287K

Transaction Codes

M
Option exercise / conversion
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001193125-26-335002) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

Build

Build on these Form 4 transactions

The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.